Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03145831 · ClinicalTrials.gov registry record · Phase 3
A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
A Phase 3 study, sponsored by Versartis.
- Terminated
- Registry status
- Phase 3
- Development phase
- 21
- Enrollment target
NCT03145831 is a Phase 3 study that was terminated before completion, run by Versartis. The registered enrollment target is 21 participants.
The verdict
NCT03145831, a Phase 3 study, was terminated before completion, sponsored by Versartis.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study is a multi-center, open-label safety study assessing long-term somavaratan administration.
Interventions
- DRUG Somavaratan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-03-31 |
| Est. Completion | 2017-11-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03145831
The ClinicalTrials.gov registry entry for NCT03145831 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Versartis, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Somavaratan is the first listed.
NCT03145831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03145831 about?
NCT03145831 is a clinical study titled "A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency". This study is a multi-center, open-label safety study assessing long-term somavaratan administration.
What is the current status of trial NCT03145831?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 21 participants. The study started on 2017-03-31. Estimated completion is 2017-11-30.
What interventions are being tested in trial NCT03145831?
The interventions under investigation include: Somavaratan (DRUG).
Who is sponsoring clinical trial NCT03145831?
This trial is sponsored by Versartis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.